Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neoplasms, Germ Cell and Embryonal × Filgrastim × Clear all

Phase

Phase 3 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma 20 Breast Neoplasms 12 Multiple Myeloma 11 Leukemia 11 Neuroblastoma 10 Lymphoma, Large B-Cell, Diffuse 10 Hodgkin Disease 10 Burkitt Lymphoma 9 Sarcoma 8 Lymphoma, Follicular 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Leukemia, Myeloid, Acute 7 Neutropenia 6 Neoplasms, Plasma Cell 6 Lymphoma, Non-Hodgkin 6 Leukemia, Myelomonocytic, Acute 6 Leukemia, Monocytic, Acute 6 Leukemia, Megakaryoblastic, Acute 6 Leukemia, Erythroblastic, Acute 6 Malignant mesenchymal tumor 5 Lymphoma, Mantle-Cell 5 Rhabdomyosarcoma 4 Lymphoma, Large-Cell, Immunoblastic 4 Immunoglobulin Light-chain Amyloidosis 4 Endometrial Neoplasms 4 Central Nervous System Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Brain Neoplasms 4 Urinary Bladder Neoplasms 3 Ovarian Neoplasms 3

Interventions

Cisplatin 4 Etoposide 3 Carboplatin 3 etoposide phosphate 2 Paclitaxel 2 Bleomycin 2 pralsetinib 1 pembrolizumab 1 pegfilgrastim 1 Standard of Care 1 Specimen Handling 1 Respiratory Physiological Phenomena 1 Practice Guidelines as Topic 1 Platinum 1 Pemetrexed 1 Magnetic Resonance Spectroscopy 1 Injections 1 Ifosfamide 1 Granulocyte Colony-Stimulating Factor 1 Gemcitabine 1 Filgrastim 1 Biopsy 1 Aprepitant 1 130-nm albumin-bound paclitaxel 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02582697 2025-06-15

P3BEP

University of Sydney

Phase 3 Recruiting

Neoplasms, Germ Cell and Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡